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This is anOpeAbstract – The neurocognitive development of infants can be positively associated with breastfeeding
exclusivity and duration. Differences in dietary lipid quality between human milk and infant milk formula
may contribute to this effect. In this review, we describe some of the known differences between humanmilk
and infant milk formula in lipid quality, including fatty acid composition, complex lipids in the milk fat
globule membrane as well as the physical properties of lipids and lipid globules. We describe some of the
underlying mechanism by which these aspects of lipid quality are thought to modulate infant brain
development such as differences in the supply and/or the bioavailability of lipids, lipid bound components
and peripheral organ derived neurodevelopmental signals to the infant brain after ingestion and on longer
term.
Keywords: human milk / infant milk formula / lipid composition / lipid structure / infant brain development
Résumé – Composition et structure des lipides du lait ; importance pour le développement du
cerveau du nourrisson. Le développement neurocognitif des nourrissons peut être associé de façon
positive à l’exclusivité et à la durée de l’allaitement. Les différences qualitatives des lipides alimentaires
entre le lait humain et les préparations lactées pour nourrissons pourraient contribuer à cet effet. Dans la
présente étude, nous décrivons certaines des différences connues entre le lait humain et les préparations pour
nourrissons en ce qui concerne la qualité des lipides, y compris la composition en acides gras, les lipides
complexes de la membrane des globules gras du lait ainsi que les propriétés physiques des lipides et des
globules lipidiques. Nous décrivons certains des mécanismes sous-jacents par lesquels ces aspects
qualitatifs des lipides pourraient moduler le développement du cerveau du nourrisson, comme les
différences dans l’apport et/ou la biodisponibilité des lipides, des composants liés aux lipides et des signaux
de neuro-développement issus d’organes périphériques et allant au cerveau du nourrisson juste après
l’ingestion et à plus long terme.
Mots clés : lait maternel / préparation lactée pour nourrisson / composition lipidique / structure lipidique /
développement du cerveau du nourrisson1 Infant feeding mode and neurocognitive
development
For mammals, the first and only source of nutrition directly
after birth is maternal milk. For humans, the current
recommendations by the World Health Organization (WHO)
for infant feeding are to exclusively breastfeed infants up to ation to theTopical Issue “Lipids and health / Lipides et santé”.
dence: lidewij.schipper@danone.com
nAccess article distributed under the terms of the Creative CommonsA
unrestricted use, distribution, and reproduction in any mleast 6months of age, with continued breastfeeding along with
appropriate complementary foods up to 2 years of age or
beyond. Although most mothers start breastfeeding, many
children do not receive mothers own milk exclusively for
6months (World Health Organization (WHO), 2017). When
mothers do not breastfeed for medical or other reasons, Infant
Milk Formula (IMF) should provide an adequate alternative.
Whereas human milk and IMF may be similar in energy
content and macronutrient composition that are needed for
infant growth and development, breast fed infants appear to
have several advantages over formula fed infants when itttributionLicense (https://creativecommons.org/licenses/by/4.0), which permits
edium, provided the original work is properly cited.
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and metabolic health (Harder et al., 2005; Jackson and Nazar,
2006; Guaraldi and Salvatori, 2012). Regarding brain
development, there are several reports that show that
breastfeeding exclusivity and duration can be positively
associated with e.g. brain structural development (Deoni et al.,
2013, 2018; Herba et al., 2013; Kafouri et al., 2013), cognitive
function (Anderson et al., 1999; Belfort et al., 2013;
Leventakou et al., 2015), behaviour, school performance
(Heikkila et al., 2014) and food intake regulation (Li et al.,
2010; DiSantis et al., 2011). This suggests that factors beyond
bulk nutritional constituents contribute to the differences
observed between breast- and formula-fed infants. Indeed,
brain development and function can be influenced by the
behavioral aspects of infant feeding (e.g. breast vs bottle
feeding (Li et al., 2010; DiSantis et al., 2011), feeding on
demand vs fixed schedule (Iacovou and Sevilla, 2013), self-
regulation vs parental encouragement for bottle emptying (Li
et al., 2008), mother-child bonding (Britton et al., 2006)), as
well as compositional differences between human milk and
formula such as the presence of bioactive components in
human milk including hormones, growth factors and immune
factors (Savino et al., 2009; Field, 2005; Ballard and Morrow,
2013; Grey et al., 2013). Furthermore, there are specific
differences between human milk and IMF in the quality of
nutrients, especially with regard to the quality of the lipid
fraction. For instance, total lipid content in IMF is fixed
whereas in human milk it is variable between and within
individuals, changing over the course of lactation, during the
day and even during a single feed (Saarela et al., 2005; Kent
et al., 2006). In addition, the quality of the lipid fraction in
human milk differs from that in IMF in at least two more
aspects. First, the composition of individual fat components,
specifically the types of fatty acids and bioactive lipid
ingredients that make up the total fat content of milk, is not the
same. Second, the (supra)molecular structure in which lipids
are organized is substantially different between human milk
and IMF. These specific aspects of lipid quality and how they
may relate to infant brain development and function will be
addressed in more detail below.
2 Milk fatty acid composition
Approximately 98% of the lipid fraction in human milk
consists of triglycerides, each containing three fatty acids (FA)
(Hamosh et al., 1985; Jensen et al., 1990). The majority of FA
in human milk are saturated fatty acids (SFA) (German and
Dillard, 2010), followed by mono-unsaturated fatty acids
(MUFA) and about 20% of the FA in human milk are omega
(n)-3 or n-6 polyunsaturated fatty acids (PUFA). These include
longer chain PUFA (carbon chain-length> 20, LCPUFA) of
the n-6 and n-3 family, such as arachidonic acid (C20:4 n-6;
ARA) and docosahexanoic acid (C22:6 n-3; DHA), as well as
their respective C18 precursors linoleic acid (C18:2 n-6; LA)
and alpha-linolenic acid (C18:3 n-3; ALA) that can be
converted to LCPUFA after ingestion (Salem et al., 1996).
Whereas the proportion of SFA and MUFA in (mature)
human milk are relatively constant, the (LC)PUFA profile may
vary in relation to maternal dietary fatty acid intake and fatty
acids released from maternal adipose tissue stores or the liverPage 2 o(Makrides et al., 1995; Innis, 2007). In particular, maternal
dietary intake of ALA, LA and DHA affects the amounts of
these specific PUFA in human milk (Koletzko et al., 1992;
Yuhas et al., 2006). For instance, the marked increase in
dietary intake of LA in the past 100 years, seen in Western-
industrialized societies as a result of increased use of vegetable
oils rich in LA (Kris-Etherton et al., 2000; Sanders, 2000;
Wolmarans, 2009), is also reflected in higher LA content in
milk of women from Europe, Australia and Northern America
(Ailhaud et al., 2006; Gibson et al., 2011). Whereas the
recommendations for fatty acid composition in IMF have been
based on human milk (Efsa panel, 2014), fluctuations from day
to day and over the course of lactation would be difficult to
mimic. Moreover, the recommended PUFA composition for
IMF has been based on milk samples analysed in a small set of
Caucasian women in a Western industrialized society context
(Efsa panel, 2014). A debate is ongoing whether or not the FA
composition in milk from this reference group can be
considered the healthiest composition for infant growth and
development (Kuipers et al., 2005; Ailhaud et al., 2006).
3 Fatty acids in the brain
Dietary supply of PUFA is essential for infant brain
development and function. Nearly 60% of the dry-weight of
the human brain consists of lipids (O’Brien and Sampson,
1965) and about 35% of the lipids in the grey matter are
LCPUFA (Benatti et al., 2004). In the neuronal membrane, the
LCPUFA support physical and functional membrane proper-
ties. Longer chain LCPUFA increase membrane fluidity due to
their more spacious structure and influence membrane
receptor, enzyme activities and neuronal plasticity (Youdim
et al., 2000). The most abundant LCPUFA in the neuronal
membrane are ARA and DHA, which rapidly accumulate in
the human brain during the first 1000 days, supporting the
rapid increase in brain volume (Martinez and Mougan, 1998).
DHA and ARA contribute to membrane physical properties
and have their own unique roles in brain development and
function. Sufficient presence of particularly DHA in the
neuronal membranes is critical as DHA contributes positively
to various processes important for neuronal growth and
development including modulating neural metabolism, differ-
entiation, plasticity, neuroprotection and anti-inflammatory
effects (see e.g. (Dyall, 2015) for review). ARA is the
precursor for specific membrane derived eicosanoids which
are important for immunity and immune responses including
the regulation of neuro-inflammation (Duncan and Bazinet,
2010; Hadley et al., 2016). Other n-3 LCPUFA in the brain,
though present in much lower concentration than DHA,
include eicosapentaenoic acid (EPA; C20:5n-3) and docosa-
pentaenoic acid (n-3 DPA, 22:5n-3), that also generate lipid
derived mediators that play a role in the inflammatory response
(Dyall, 2015) and in particular EPA stimulates neurite
outgrowth during development (Robson et al., 2010). DPA
from the n-6 family (n-6 DPA; 22:5n-6) is the structural
homologue of DHA and typically accumulates in the brain
when DHA supply is insufficient (Foot et al., 1982; Carrie
et al., 2000). This compensatory mechanism ensures that the
total brain volume remains the same, however, n-6 DPA
cannot fulfill the specific neurodevelopmental roles of DHAf 11
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Katakura et al., 2013). High levels of n-6 DPA are therefore
considered disadvantageous. Preferential accumulation of
DHA in the brain occurs at high rate between the 3rd trimester
up to 2 years of age, and accumulation extends into childhood
and adolescence (Martinez, 1992; Carver et al., 2001). This
pattern parallels active brain development and further
illustrates the importance of DHA for brain development
and function throughout life. Indeed, it is well-documented in
animal studies that perinatal depletion of brain DHA leads to
enduring abnormalities including altered morphology, neuro-
transmission and (long term) functional impairments including
impairments in cognitive performance and visual acuity and
increased risk for depression/anxiety (Neuringer et al., 1986;
Greiner et al., 1999; Moriguchi et al., 2000; Ahmad et al.,
2002; Carrie et al., 2002; Garcia-Calatayud et al., 2005;
Chalon, 2006; Clouard et al., 2015). Importantly, once
established, these alterations cannot be fully restored by
supplementing with n-3 LCPUFA during later life stages
(Carrie et al., 2000; Ikemoto et al., 2001; Anderson et al.,
2005). In humans, a direct association between brain LCPUFA
composition and behaviour or cognition is difficult to
demonstrate as this would require the analysis of brain tissue.
However, prospective studies have shown that fœtal cord
blood DHA levels –which may serve as a proxy for brain
PUFA status at birth – are inversely related to internalizing
problem behaviour, hyperactivity and inattention in childhood
(Krabbendam et al., 2007; Kohlboeck et al., 2011), whereas
higher levels of n-3 LCPUFA are associated with better motor
performance, (Bakker et al., 2009), higher scores in cognitive
functioning (Bakker et al., 2003; Boucher et al., 2011) and
better neurological scores (Escolano-Margarit et al., 2011).
Moreover, low DHA and n-3 LCPUFA or increased n-6
LCPUFA concentration in adult brain has been related to
neuropsychiatric disease (McNamara et al., 2007; Conklin
et al., 2010; Hamazaki et al., 2013). These studies show that
DHA in the brain is critical for brain function and mental
health in humans, further highlighting the importance of
sufficient DHA accumulation during infancy.
4 Dietary fatty acids are used as building
blocks for the developing brain
The developing brain relies on the plasma pool of
LCPUFA for DHA accumulation. Although the brain is able
to generate some DHA by endogenous synthesis from
precursor n-3 LCPUFA in glial cells (Williard et al., 2001),
DHA synthesis in the brain occurs at a much lower rate than
the total rate of brain accretion of DHA needed to support
growth and development (Demar et al., 2005; Kitson et al.,
2016). In plasma, DHA and other LCPUFA are present in two
major pools;
– bound albumin, as non-esterified fatty acid (NEFA)-DHA
or lysophosphatidylcholine-esterified (LPC)-DHA;– in lipoproteins esterified to e.g. TG, PL, cholesterol, PL or
other lysophospholipids.There is no consensus on what lipid form in the plasma pool is
preferentially used for accumulation in the brain (Bazinet and
Laye, 2014; Chen et al., 2015; Liu et al., 2015), nor are the
mechanisms agreed upon by which these various forms ofPage 3 ocirculating PUFA are delivered  either by protein-mediated
and/or passive diffusion (Mitchell and Hatch, 2011). The
uptake process from plasma to tissue appears to be non-
selective for n-6 and n-3 LCPUFA. The accumulation of DHA
in the brain is therefore dependent on the total and relative
levels of DHA and other n-3 as well as n-6 LCPUFA in the
plasma (Hibbeln et al., 2006; Igarashi et al., 2009).
In turn, the level of circulating n-3 and n-6 LCPUFA are
influenced by the infant’s diet. Preformed LCPUFA are present
in human milk or IMF and LCPUFA can be synthesized
endogenously based on the supply of the precursors LA and
ALA in milk (Gibson et al., 2011). The capacity of LCPUFA
synthesis from LA and ALA is low in humans (Burdge and
Wootton, 2002; Brenna et al., 2009). Although infants (both
preterm and term) may have a similar capacity as adults to
convert LA to AA, and ALA to DHA (Innis, 2003, 2007), the
activity seems insufficient to fulfill the high LCPUFA
requirements needed for growth and development in infancy,
in particular for DHA (Decsi and Koletzko, 1995; Giovannini
et al., 1995). Preformed DHA in the infant’s diet therefore is
considered conditionally essential (Muskiet et al., 2004;
BrennaandCarlson,2014). Humanmilk contains a considerable
amount of LCPUFA in preformed state. It has been suggested
that one of the reasons for the advantages of breastfeeding over
formula feeding regarding brain development is related to the
high concentration of LCPUFA in human milk, especially the
natural presence of DHA (Michaelsen et al., 2009). Postmor-
tem studies in the past have revealed that infants fed formula
without DHA had lower brain DHA levels and higher n-6
LCPUFA compared to age-matched breast-fed infants
(Farquharson et al., 1992; Makrides et al., 1994; Martinez
and Mougan, 1998; Jamieson et al., 1999). DHA accumulation
in the infant brain is, however, not only dependent on the
supply of preformed DHA in the infant diet. The biosynthesis
of LCPUFA from LA and ALA in the liver and other tissues
involves a series of elongation and desaturation steps. LA and
ALA use the same set of enzymes for conversion to ARA and
DHA and therefore compete with each other. High dietary
supply of LA inhibits endogenous DHA synthesis and results
in higher n-6 LCPUFA in the circulation, which further limits
DHA incorporation in the developing brain as circulating n-3
and n-6 LCPUFA compete for uptake by the brain as well
(Lefkowitz et al., 2005; Gibson et al., 2011). In line with this,
the level of LA in human milk, independent of milk n-3
LCPUFA level, has been inversely correlated to infant
cognitive development and function (Lassek and Gaulin,
2014; Bernard et al., 2015, 2017). In a piglet study, it was
found that a formula containing high LA increased the
accumulation of n-6 LCPUFA and reduced DHA and other n-3
LCPUFA in the brain. Moreover, increasing DHA content
failed to prevent some of the impairments in the brain fatty acid
profile that were induced by the high supply of LA (Novak
et al., 2008). Rodent studies have shown that lowering the
postnatal dietary LA supply can stimulate brain DHA
accumulation (Schipper et al., 2016a), alter the structural
development of neuronal networks (Schipper et al., 2013) and
protect the developing brain against early life stress-induced
neurocognitive impairments in adulthood (Yam et al., 2019).
Due to the persistent changes in, for example, serotonergic and
dopaminergic neurotransmitter systems that are linked to early
life impaired brain DHA accumulation (Chalon, 2006), it hasf 11
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supply of LA and low supply of DHAmay also contribute to the
increased incidence of neurological and psychiatric disorders
such as depression and schizophrenia that has been observed
over the last decades (Klerman and Weissman, 1989; Muskiet,
2010; McNamara, 2013; Grosso et al., 2014).
As can be derived from the examples described above,
ensuring adequate levels of n-3 LCPUFA, as well as prevention
of excessive n-6 (LC)PUFA in the infant’s diet appear to
support n-3LCPUFA accumulation in the brain and may
thereby contribute to optimal development and functioning of
the infant brain. Many studies have therefore attempted to
increase infant neurocognitive outcomes by (maternal) n-3
LCPUFA supplementation. However, for healthy term infants
this supplementation has not always shown clear benefits
(Simmer et al., 2008; Delgado-Noguera et al., 2010; Qawasmi
et al., 2012), although maternal n-3 LCPUFA supplementation
during lactation seems more effective than n-3 LCPUFA
supplementation of IMF (Lauritzen et al., 2016). Yet, it seems
unlikely that differences between LCPUFA composition in
human milk and formula alone could explain the beneficial
effects of breastfeeding over formula feeding on infant health
and neurodevelopmental outcomes.
5 Milk fat globules
Mammalian milk has a distinct lipid composition and
physical structure as a result of the physiological process by
which the fat globules are produced and secreted from the
mammary gland. Human milk lipid droplets are large, ranging
in diameter from 0.2 to more than 15mmwith an average mode
diameter of 4mm inmature milk (Michalski et al., 2005). Lipid
globules are larger in early colostrum than in mature milk
(Simonin et al., 1984; Michalski et al., 2005; Zou et al., 2012),
but the size remains stable during the day (Michalski et al.,
2005) and during a single feed (Zou et al., 2012). In mammary
gland cells, milk triglycerides are synthesized in the
endoplasmatic reticulum and aggregate in small lipid droplets
that are surrounded by a single layer of polar lipids and
proteins. In the cytoplasm of the mammary gland cell, several
of these microlipid droplets fuse to form larger lipid droplets
that migrate through the cell to their secretion site. Upon
secretion, the plasma membrane of the mammary gland cell
encloses the lipid droplet, resulting in a three-layer biological
membrane that surrounds the large TG core, which is known as
the milk fat globule membrane (MFGM) (Wooding, 1971;
Mather and Keenan, 1998; Heid and Keenan, 2005; Martini
et al., 2016). The composition of the MFGM equals that of
other biological membranes, containing complex polar lipids
such as phospholipids (PL), gangliosides, sphingomyelin and
cholesterol (Lopez and Menard, 2011), which together
represent the remaining 1–2% of the total lipid fraction in
milk (Singh, 2006; Contarini and Povolo, 2013). The PLs are
mainly located in the outer bilayer of the MFGM, while
cholesterol and sphingomyelin are primarily aggregated in
rigid domains in the membranes called lipid rafts (Gallier et al.,
2010). The most important PLs in the MFGM are phosphati-
dylcholine (PC), phosphatidylethanolamine (PE), phosphati-
dylinositol (PI), phosphatidylserine (PS) and sphingomyelin
(Contarini and Povolo, 2013; Giuffrida et al., 2013).Page 4 oWhereas factory-produced composition of IMF is based on
the total lipid content and fatty acid composition of human
milk, it does not take into account the specific structural
organization of lipid droplets seen in human milk. Due to
processing steps like homogenization and emulsification in
IMF production, the lipid droplets have a much smaller
diameter (about 0.3–1.0mm) compared to those seen in raw
milk (Michalski et al., 2005; Ye et al., 2008). Moreover, there
is no biological membrane surrounding the lipid globules in
standard IMF. Most commercially available infant formulas
contain only triglycerides as source of lipids although IMF’s
with added MFGM fragments are increasing in popularity.
6 Milk fat globule membrane (components)
as bioactive ingredient
Although representing only a small proportion of the total
lipid fraction, the natural presence of MFGM complex lipids in
human milk may contribute to the differences in neuro-
cognitive development observed between breast- and formula
fed infants. Studies in rodents and piglets have shown that
early life dietary supplementation with MFGM or individual
MGFM components such as gangliosides and sphingomyelin
can positively influence brain development and functions
including neuroplasticity (Guillermo et al., 2015), myelination
(Oshida et al., 2003) and cognitive performance (Wang et al.,
2007; Vickers et al., 2009; Liu et al., 2014a; Guan et al., 2015).
Interestingly, a recent study in growth-restricted rat pups
suggested that supplementation with MFGM fragments
resulted in better neurodevelopmental outcomes than supple-
mentation with some of the individual components present in
MFGM (Brink et al., 2019). Human infants born preterm
showed improved neurobehavioral development during
infancy when exposed to sphingomyelin-fortified milk
(Tanaka et al., 2013) and healthy term infants showed
improved cognitive function at 6months of age following
dietary ganglioside supplementation (Gurnida et al., 2012).
Moreover, at 12months of age, the cognitive score of infants
exposed to an IMF with reduced protein density and added
MFGM fragments until 6months of age was higher than that of
infants fed standard formula and closer to that of a breast fed
reference group (Timby et al., 2014). It is hypothesized that the
complex lipids in the MFGMmay serve as building blocks and
or developmental signals for the infant brain. Like LCPUFA,
complex lipids in MFGM such as PL, sphingolipids,
gangliosides, and cholesterol can also be found as structural
components of neuronal membranes (Kracun et al., 1992;
Bjorkhem and Meaney, 2004; Posse de Chaves and Sipione,
2010; Zhang and Liu, 2015). These lipids play an important
role in brain development, affecting a variety of processes
including neurotransmission, neurogenesis, synaptogenesis,
modulating synaptic transmission, cell proliferation, and
neuronal differentiation and myelination (Mauch et al.,
2001; Saher et al., 2005; Palmano et al., 2015). Moreover,
some of these complex lipids in MFGM contain (conditionally)
essential nutrients required for brain development such as sialic
acid, a component in gangliosides, and choline, present in
phosphatidylcholine and sphingomyelin (Zeisel, 2000, 2004;
Wang, 2012). These complex lipids may be absorbed by the
intestine as whole (McJarrow et al., 2009) or as individualf 11
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where they are incorporated in neuronal membranes or used
again as a precursor for denovobiosynthesis of brain lipids (Reis
et al., 2016). A higher dietary supply of MFGM (components)
therefore increase the presence of these lipids in the neuronal
membranes. Indeed, breast-fed infants were shown to have a
higher brain ganglioside and sialic acid concentration than
infants that had been fed a standard formula inwhich the content
of these components is low (Wang et al., 2003). In rats, early life
supplementation with dietary gangliosides increased brain
ganglioside content (Park et al., 2005; Gustavsson et al.,
2010) and the brain phospholipid composition of rats artificially
reared on a formula supplemented with MFGM, compared to
standard formula, was closer to that of mother-reared rats
(Moukarzel et al., 2018). Although there is no information
available on dietary cholesterol and brain cholesterol levels
in human infants, increased brain cholesterol levels were
found after early life dietary supply of cholesterol in
piglets (Boleman et al., 1998) and rodents (Morris and
Chaikoff, 1961).
7 The physical properties of lipids and lipid
globules
In addition to the different supply of bioactive lipid
ingredients, the unique physical properties of lipids in human
milk compared to that of lipids in infant formula may
contribute to the beneficial effects of breastfeeding on infant
brain development (Ortega-Anaya and Jimenez-Flores, 2019).
The MFGM that surrounds the large lipid globule in human
milk comprises a triple PL layer, each PL containing two FA
tails. In human milk, about 15% of the LCPUFA are PL bound
(Koletzko and Rodriguez-Palmero, 1999) while standard IMF
usually contains TG only. Similar to total fat and FA
composition of the TG fraction in human milk, the FA
composition of the PL fraction in the MFGM is influenced by
the maternal diet and the stage of lactation (Lopez et al., 2008;
Zou et al., 2012). In itself, the molecular structure (i.e. PL vs
TG) of dietary LCPUFA can influence the digestion and
absorption kinetics after ingestion, and the subsequent
bioavailability of LCPUFA in the plasma for the developing
brain (Amate et al., 2001; Michalski et al., 2013). Studies in
infants and healthy adult volunteers have shown that PL-bound
LCPUFA in the diet, including DHA, are better absorbed than
TG-bound LCPUFA (Carnielli et al., 1998; Morgan et al.,
1998; Ulven et al., 2011; Ramprasath et al., 2013). The
molecular structure of dietary PUFA may differentially affect
their distribution in plasma fatty acid pools (NEFA, LPC,
esterified) after digestion and absorption and can thereby
influence the total and temporal availability for uptake by the
brain (Amate et al., 2001; Kitson et al., 2016). Regardless of
the plasma lipid pool, there are several preclinical studies that
show that dietary PL-bound LCPUFA, including DHA, more
effectively target the brain than dietary LCPUFA supplied as
TG (Mathews et al., 2002; Wijendran et al., 2002; Graf et al.,
2010; Liu et al., 2014b; Kitson et al., 2016). This also applies
to the precursors of LCPUFA, as PL bound ALA was more
effective than TG bound ALA in restoring brain DHA levels
after perinatal dietary n-3 LCPUFA deficiency in rats
(Delplanque et al., 2013).Page 5 oAdding to molecular structure, the supramolecular
structure of dietary lipids in human milk may also influence
the bioavailability of PUFA for the developing brain. In human
milk, lipid droplets are large and are enveloped by the MFGM,
whereas lipid droplets in IMF (regardless of added MFGM
ingredients) are small and do not have the complex surface
area. The lipid droplet size and complexity of the surface area
are factors known to affect (temporal) absorption and digestion
kinetics, influencing the pattern of lipid appearance in the
circulation after ingestion and thus their bioavailability for
developing organs (Armand et al., 1996, 1999; Michalski
et al., 2006, 2013; Bourlieu et al., 2015; van Aken, 2010).
Recently, a novel concept IMF was developed with large lipid
globules surrounded by a phospholipid membrane, resembling
more closely the supramolecular structure of lipid droplets in
human milk (Gallier et al., 2015). In adult volunteers, it was
shown that consumption of this concept IMF resulted in a
faster postprandial increase in plasma TG and earlier peak
NEFA concentrations compared to regular IMF (Baumgartner
et al., 2017). Whereas potential beneficial effects of this
concept IMF on brain LCPUFA accumulation pattern early in
life remain to be confirmed, it was shown that early life
consumption of this concept IMF improved cognitive
functions in mice during adolescence and adulthood (Schipper
et al., 2016b).
Alternatively, it can be hypothesized that the supramo-
lecular structure of lipid droplets can influence neurocognitive
function via the different release gut hormones that target the
brain beyond satiety regulation. Due to the changes in lipid
digestion and absorption kinetics, the postprandial pattern of
satiety hormones is altered (Ohlsson et al., 2014). The concept
IMF that mimics the supramolecular structure of lipid droplets
in human milk was also reported to evoke prolonged release of
the small intestine derived satiety hormone cholecystokinin
(CCK) (Baumgartner et al., 2017). CCK and other lipid-
induced satiety signals have been reported to facilitate learning
and memory processes (Monnikes et al., 1997; Gulpinar and
Yegen, 2004; Campolongo et al., 2009). A different pattern of
release during critical periods of growth and development may
alter developmental trajectories of brain centres involved in
neurocognitive function. Studies that compare the postprandial
hormone release in infants following consumption of human
milk vs IMF are limited in number but do confirm differences
depending of feeding mode (Lucas et al., 1981; Salmenpera
et al., 1988; Slupsky et al., 2017). Recent studies also showed
that the profiles of fasting state appetite regulating hormones
including insulin and leptin were different between breast- and
formula-fed infants (Breij et al., 2017; Vasquez-Garibay et al.,
2019). Moreover, these hormones have associated with brain
development and cognitive function (Plagemann et al., 2005;
Farr et al., 2015; Cato and Hershey, 2016).
8 Influence of other organs and organ
derived factors
On the longer term, differences between breast- and
formula-fed infants in growth patterns and associated diffe-
rences in organ development and functions that are mediated
by differences in dietary lipid quality, may also influence brain
development and or function. Recent work suggests forf 11
L. Schipper et al.: OCL 2020, 27, 5instance that skeletal development is a determinant of brain
development, neuronal structure and behavioural function.
Bone tissue secretes the hormone osteocalcin (OCN), which
was shown to be higher in serum from breast- compared to
formula-fed infants (Michaelsen et al., 1992). OCN crosses the
blood brain barrier to promote synthesis of several neuro-
transmitters including serotonin, dopamine, NA and reduces
GABA during postnatal life (Oury et al., 2013). Mice lacking
OCN show increased anxiety, depression and impaired
learning and memory (Oury et al., 2013). OCN synthesis is
dependent on the maturity of the osteoblast and on the lipid
soluble factors vitaminD and K (Skjodt et al., 1985; Gundberg
et al., 2012; van Driel and van Leeuwen, 2014), of which
absorption could be increased by the supramolecular structure
in human milk (Bezelgues et al., 2009). Also, the generally
accepted link between early life dietary supplementation with
n-3 LCPUFA (and or dietary low n-6 LA exposure) and
cognitive and behavioural function could be mediated, in part,
by enhanced bone development. High levels of ARA-derived
prostaglandin 2 were shown to impair bone formation (Baylink
et al., 1993) and omega-3 fatty acid supplementation in young
rats and mice amplified bone formation and OCN secretion
(Watkins et al., 2000; Bonnet and Ferrari, 2011; Bonnet and
Ferrari, 2015).9 Implications for human health
Human infants in our modern society may face many
challenges during the first 1000 days that can affect brain
development and are associated with higher risks for both
mental and metabolic diseases. The WHO estimates that about
one-third of the adult population suffers from a mental or
neurological disorder (Kessler et al., 2009) and children and
adolescents are increasingly affected (Polanczyk et al., 2015).
As effective treatment of mental disorders is not only time
consuming and expensive, but often simply not possible,
prevention is key. A preventative rather than reactive approach
in management of brain disorders is crucial. Prolonged
breastfeeding is associated with better neurodevelopmental
outcomes (Horwood and Fergusson, 1998; Belfort et al., 2013;
Heikkila et al., 2014; Horta et al., 2015; Leventakou et al.,
2015), which extends into later in life higher educational/
academic performance (Horwood and Fergusson, 1998;
Victora et al., 2015) and reduced risk of later mental and
behavioural problems (Montgomery et al., 2006; Oddy et al.,
2010; Hayatbakhsh et al., 2012). Whereas possible confound-
ing circumstances such as differences in parental education,
health and food habits cannot be fully excluded in these human
trials, the published evidence so far suggests that differences in
dietary lipids quality could contribute to this.
Providing a more optimal balance of n-3 and n-6 PUFA in
early life could be instrumental. Practically, this goal can be
reached through more specific dietary advice to pregnant and
lactating women regarding fatty acid intake. Although the
importance of (maternal) dietary intake n-3 LCPUFA for infant
brain development is well known to the public, the potential
adverse effects of high intakes of LA, and therefore the
importanceof lowering levels ofLA in the (maternal) diet arenot
yet taken into account in current dietary recommendations.
Lowering dietary intake of LA can be reached by replacing thePage 6 oconsumptionof standardvegetableoils (sunflower, soybean) and
food items containing substantial LA quantities such as
salad dressings and snack food by alternative food products
containing oils and food products lower in LA (MacIntosh et al.,
2013; Wood et al., 2013, 2014). These dietary advices are
relatively simple, cheap and home-based and therefore have
the potential to reach a broad public. In line with this, the
regulation for fatty acid composition in nutritional products for
infants and young children should be critically reviewed. For
instance, the recommendations of the 2014 European Food
Safety Authority Panel on Dietetic Products, Nutrition and
Allergies include for LA a lower and upper bound range of 0.5
and 1.2 g/100 kcal IMF, combined with 0.05 to 0.1 g/100 kcal
IMF for ALA, an no maximal permitted LA/ALA ratio (Efsa
panel, 2014).Whereas the current recommendation now include
addition ofpreformedDHA,butnotARA, reconsideration of the
upper levels of LA in particular may be a strategy that could
support healthier (brain) development of infants (Kuipers et al.,
2005; Muskiet et al., 2006; Gibson et al., 2011). In addition to
lipid composition, the supramolecular structure of dietary lipids
may be a promising target to explore inmore detail as the typical
structural organization of dietary lipids in humanmilk, i.e. being
present as large lipid droplets enveloped by the MFGM, may
contribute to some of these benefits. Mimicking the supramo-
lecular structure of lipid droplets in human milk more
closely could further improve IMF lipid quality and support
brain development of formula fed or mixed fed infants
specifically.
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